Have library access?
IP:18.97.14.91
  • Journals

Comparing Outcomes of Two Implanted Port Central Venous Access Devices in Cancer Patients

癌症病患兩種中央靜脈導管系統之結果比較

Abstracts


Background: This study investigated the incidences of thrombosis occlusion, infection and surgical complications between two commercially available implanted port systems. The survival of port-A devices were analyzed. Study Design: Medical records from 313 cancer patients who had received open-ended (Deltec) or closed-ended (Groshong) implanted port catheter insertions were retrospectively reviewed. Methods: The crude infection rates, thrombosis rates, surgical complication rates (chi-square test), as well as total catheter indwelling days (t-test) were compared between closed- and open-ended implanted port system insertion groups. A Kaplan Meier analysis and a stratified log rank test were used to compare the probabilities of infection/thrombosis-free days of the 2 insertion groups. Logistic and multivariate regression models were applied to analyze the outcome predictors. Results: The Groshong catheters (561±386.7 days) had greater (P<0.001) mean total catheter indwelling days than did Deltec catheters (231±226.8 days). But the crude infection, thrombosis, and surgical complication rates failed to show statistically significant differences (P>0.05) between closed- and open-ended implanted port system insertion groups. Surgical procedure (P=0.0002) and catheter type (P<0.0001) were predictive of total catheter indwelling days. However, 2 types of catheters had similar survival rates at the end of follow up (P>0.05). Conclusion: Even though the Groshong closed-ended catheter may have a marginal advantage in total catheter indwelling days, we found the crude infection, thrombosis occlusion, and device survival rates were similar between Deltec and Groshong groups.

Keywords

No data.

Parallel abstracts


Background: This study investigated the incidences of thrombosis occlusion, infection and surgical complications between two commercially available implanted port systems. The survival of port-A devices were analyzed. Study Design: Medical records from 313 cancer patients who had received open-ended (Deltec) or closed-ended (Groshong) implanted port catheter insertions were retrospectively reviewed. Methods: The crude infection rates, thrombosis rates, surgical complication rates (chi-square test), as well as total catheter indwelling days (t-test) were compared between closed- and open-ended implanted port system insertion groups. A Kaplan Meier analysis and a stratified log rank test were used to compare the probabilities of infection/thrombosis-free days of the 2 insertion groups. Logistic and multivariate regression models were applied to analyze the outcome predictors. Results: The Groshong catheters (561±386.7 days) had greater (P<0.001) mean total catheter indwelling days than did Deltec catheters (231±226.8 days). But the crude infection, thrombosis, and surgical complication rates failed to show statistically significant differences (P>0.05) between closed- and open-ended implanted port system insertion groups. Surgical procedure (P=0.0002) and catheter type (P<0.0001) were predictive of total catheter indwelling days. However, 2 types of catheters had similar survival rates at the end of follow up (P>0.05). Conclusion: Even though the Groshong closed-ended catheter may have a marginal advantage in total catheter indwelling days, we found the crude infection, thrombosis occlusion, and device survival rates were similar between Deltec and Groshong groups.

Read-around